ConductScience.org, home

Library / Genes

KLRB1: killer cell lectin like receptor B1

1 protein, 64 patents, 0 drugs, 0 trials, 2,895 NIH grants and 4,872 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolKLRB1HGNC
Namekiller cell lectin like receptor B1HGNC
NCBI Gene ID3820NCBI Gene
HGNC IDHGNC:6373HGNC
EnsemblENSG00000111796NCBI Gene
AliasesCD161, CLEC5B, NKR, NKR-P1, NKR-P1A, NKRP1A, hNKR-P1ANCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q12918Killer cell lectin-like receptor subfamily B member 12253Ensembl, GeneID, HGNCUniProt

Patents 64

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4753741 A12026-06-10483Q12918Espacenet
JP 2026515717 A2026-05-19341Q12918Espacenet
JP 2026502764 A2026-01-271Q12918Espacenet
JP 2026004568 A2026-01-1450756Q12918Espacenet
US 12460007 B22025-11-04921Q12918Espacenet
EP 4641202 A22025-10-2932Q12918Espacenet
JP 2025529142 A2025-09-042312Q12918Espacenet
EP 4608858 A22025-09-031Q12918Espacenet
US 12371689 B22025-07-292312Q12918Espacenet
JP 2025519056 A2025-06-241Q12918Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 2895

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
U19AI082630Durable Alteration of the Human Immune system after Infection or Immunotherapy282,025NIH's project files
U19AI057229Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro212,025NIH's project files
P30CA008748Cancer Center Support Grant192,025NIH's project files
P51OD011132Emory National Primate Research Center162,025NIH's project files
P30CA016672Cancer Center Support Grant142,025NIH's project files
P30CA016058Cancer Center Support Grant132,025NIH's project files
P01CA065493Off-the-Shelf Immune Effector Cells for Hematological Malignancies122,025NIH's project files
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success112,025NIH's project files
P30AI027763UCSF-Bay Area Center for AIDS Research92,025NIH's project files
P30AR070253Joint Biology Consortium Resource-based Center92,025NIH's project files

Papers 4872

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42825901PubTator, text miningPubMed
42793134PubTator, text miningPubMed
42764351PubTator, text miningPubMed
42744148PubTator, text miningPubMed
42688053PubTator, text miningPubMed
42685688PubTator, text miningPubMed
42675604PubTator, text miningPubMed
42630167PubTator, text miningPubMed
42585835PubTator, text miningPubMed
42582947PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license